Open AccessEarly Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study
Author(s) -
Attyla Drabik,
Andreas Sturm,
Margit Blömacher,
Ulf Helwig
Publication year - 2016
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/resprot.5791
Subject(s) - golimumab , medicine , ulcerative colitis , calprotectin , vedolizumab , discontinuation , infliximab , clinical trial , adalimumab , tumor necrosis factor alpha , gastroenterology , inflammatory bowel disease , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom